Exodus Point Capital Management, LP Kezar Life Sciences, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$6.39 - $8.8 $20,428 - $28,133	-3,197 Reduced 6.41%	46,675 $329,000
Q3 2022 Nov 10, 2022	SELL	$7.99 - $10.75 $1.38 Million - $1.86 Million	-172,860 Reduced 77.61%	49,872 $429,000
Q2 2022 Aug 19, 2022	BUY	$4.58 - $17.13 $1.02 Million - $3.82 Million	222,732 New	222,732 $1.84 Million
Q1 2022 May 13, 2022	SELL	$12.3 - $18.33 $195,299 - $291,043	-15,878 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$7.44 - $16.72 $118,132 - $265,480	15,878 New	15,878 $265,000
Q2 2021 Aug 16, 2021	SELL	$4.93 - $6.46 $87,103 - $114,135	-17,668 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.24 - $6.99 $92,580 - $123,499	17,668 New	17,668 $105,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.